Ventas (FRA:VEN) Quality Rank


FRA:VEN Ventas Inc FRA:VEN
79 GF Score
Price €81.80
GF Value €62.26
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ventas Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Ventas Quality Rank Related Terms

FRA:VEN
79GF Score
Ventas Inc FRA:VEN
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ventas (FRA:VEN) Overvalued in 2026?

Based on GuruFocus' analysis, Ventas stock appears to be overvalued. The current stock price of €81.80 is trading 31.4% above its estimated GF Value™ of €62.26. GuruFocus considers Ventas to be Significantly Overvalued.

Key valuation signals for FRA:VEN:

  • Quality Rank:
  • GF Value™: €62.26 vs. price of €81.80 (31.4% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the FRA:VEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ventas Business Description

Industry Real EstateREITs
Address 300 North LaSalle Street, Suite 1600, Chicago, IL, USA, 60654
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
79GF Score

Get the complete analysis for FRA:VEN

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€81.80
Price
€62.26
GF Value